3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
16
Rituximab
14
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
fludarabine phosphate
7
fludarabine
7
Specimen Handling
7
Prednisone
7
Etoposide
6
Biopsy
6
tocilizumab
5
polatuzumab vedotin
5
ibrutinib
5
X-Rays
5
Whole-Body Irradiation
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Lenalidomide
5
Doxorubicin
5
Mycophenolic Acid
4
Cytarabine
4
Cyclosporine
4
Busulfan
4
venetoclax
3
pembrolizumab
3
glofitamab
3
acalabrutinib
3
Vincristine
3
Tacrolimus
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
2C4 antibody
×
30 days
×
Clear all
No trials found.